Literature DB >> 7963538

Dominant chymotrypsin-like esterase activity in human lymphocyte granules is mediated by the serine carboxypeptidase called cathepsin A-like protective protein.

W L Hanna1, J M Turbov, H L Jackman, F Tan, C J Froelich.   

Abstract

We identified a chymotrypsin-like activity in the granules of IL-2 lymphokine-activated killer (LAK) cells and a NK cell line (YT) that reacted preferentially with the oligopeptide substrate succinyl-Phe-Leu-Phe-thiobenzyl ester (Suc-Phe-Leu-Phe-SBzl). The enzyme was isolated by detergent extraction of sedimented cytotoxic granules and then by a sequence of sieve, hydrophobic, and anion exchange chromatography. On SDS-PAGE, the protein migrated at 42 kDa in nonreduced form and became two bands (31 and 19 kDa, respectively) after reduction. Amino-terminal sequencing of the reduced protein bands revealed 100% homology with cathepsin A-like protective protein (CAPP), a lysosomal enzyme that expresses serine carboxypeptidase and deamidase activities. The carboxypeptidase activity of lymphocyte CAPP was verified by showing that the protease preferred hydrophobic amino acids in the penultimate position of the C terminus (i.e., cleaved arginine from dansyl-Phe-Leu-Arg). The presence of lymphocyte CAPP in secretory lysosomes was demonstrated by showing that Suc-Phe-Leu-Phe-SBzl activity co-migrated with tryptase and Asp-ase activities on Percoll density gradients and that 95% of the Suc-Phe-Leu-Phe-SBzl activity in granule fractions of cavitated YT cells could be immunoprecipitated with an anti-CAPP antiserum. In addition, calcium ionophore-stimulated YT cells were shown to secrete immunoprecipitable CAPP. As proposed for platelets, lymphocyte CAPP may be secreted to function extracellularly by inactivating bioactive peptides.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963538

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Control of death receptor ligand activity by posttranslational modifications.

Authors:  R Weinlich; T Brunner; G P Amarante-Mendes
Journal:  Cell Mol Life Sci       Date:  2010-03-20       Impact factor: 9.261

Review 2.  Lysosomal multienzyme complex: pros and cons of working together.

Authors:  Erik J Bonten; Ida Annunziata; Alessandra d'Azzo
Journal:  Cell Mol Life Sci       Date:  2013-12-15       Impact factor: 9.261

3.  The atomic model of the human protective protein/cathepsin A suggests a structural basis for galactosialidosis.

Authors:  G Rudenko; E Bonten; W G Hol; A d'Azzo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

4.  Protective protein/cathepsin A down-regulates osteoclastogenesis by associating with and degrading NF-kappaB p50/p65.

Authors:  Masaaki Masuhara; Takuya Sato; Naoto Hada; Yoshiyuki Hakeda
Journal:  J Bone Miner Metab       Date:  2008-12-05       Impact factor: 2.626

5.  Cathepsin A regulates chaperone-mediated autophagy through cleavage of the lysosomal receptor.

Authors:  Ana Maria Cuervo; Linda Mann; Erik J Bonten; Alessandra d'Azzo; J Fred Dice
Journal:  EMBO J       Date:  2003-01-02       Impact factor: 11.598

6.  Galactosialidosis: historic aspects and overview of investigated and emerging treatment options.

Authors:  Ida Annunziata; Alessandra d'Azzo
Journal:  Expert Opin Orphan Drugs       Date:  2016-12-14       Impact factor: 0.694

7.  Serine carboxypeptidase SCPEP1 and Cathepsin A play complementary roles in regulation of vasoconstriction via inactivation of endothelin-1.

Authors:  Xuefang Pan; Lubov Grigoryeva; Volkan Seyrantepe; Junzheng Peng; Katrin Kollmann; Johanne Tremblay; Julie L Lavoie; Aleksander Hinek; Torben Lübke; Alexey V Pshezhetsky
Journal:  PLoS Genet       Date:  2014-02-27       Impact factor: 5.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.